Condition: Advanced Cancers Associated With Mesothelin Expression
Intervention: Biological: HPN536
Sponsor: Harpoon Therapeutics
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 21, 2019ClinicalTrials.govComments OffHepatology(Liver, Pancreatic, Gall Bladder)Advanced | Associated | Cancers | Expression | HPN536 | Mesothelin | Patients | Study
